SEC Filing Details

SEC Filing Details

Document Details

Form
424B5
Filing Date
Nov 9, 2022
Document Date
Nov 9, 2022
Form Description
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3
Filing Group
Registration Statements
Company
ReShape Lifesciences
Issuer
RESHAPE LIFESCIENCES INC.
For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE